StockData
Spectral AI, Inc. logo

Spectral AI, Inc. (MDAIW) stock

MDAIWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as MDAI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 0/30
$0.45−0.04 (-8.55%)

Close on Oct 30, 2026Market cap $49.24MP/E –Yield –

Spectral AI, Inc. saw revenue fall 44.1% to $15.39M over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $49.24M.

Revenue
$15.39M
-44.1% vs. a year earlier
Operating income
-$11.88M
TTM Q2 2026
EPS, diluted
-$0.34
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$49.24M
P/E ratio
–
Price to sales
3.20
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$15.39M
Net income
-$10.09M
EPS, diluted
-$0.34
Book value per share
-$0.38
Diluted shares
32M

Trading

Previous close
$0.49
Open
$0.48
Day's range
$0.41 – $0.49
Volume
4,219
Average volume (20 days)
8,576
Beta (5 years)
0.52
52-week range
$1.18 – $2.97
RSI (14 days)
45.6
Volatility (1 year)
63.3%
Relative volume
0.75×
WACC
7.7%

Market cap history

Month-end market cap since 2023, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.

PeriodMDAIWS&P 500DifferenceMDAIW per yearS&P 500 per year
1 month-4.7%-0.9%−3.8 pts
3 months-4.7%+2.1%−6.8 pts
Year to date-0.4%+11.7%−12.1 pts
1 year-38.6%+12.4%−51.0 pts
3 years+220.1%+88.6%+131.5 pts+47.4%+23.5%
5 years-32.1%+75.9%−108.0 pts-7.5%+12.0%

Six years at a glance

Fiscal years 2020 to 2025 and trailing twelve months, USD

Revenue

$15.39M-44.1% YoY

Gross profit

$6.61M-47.0% YoY

Operating income

-$11.88M

Net income

-$10.09M

EPS, diluted

-$0.34
Reported periodTrailing twelve months

Press releases

Releases Spectral AI filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Spectral AI

Surgical & Medical Instruments & Apparatus

Spectral AI, Inc. develops predictive medical diagnostic solutions driven by artificial intelligence. Its primary offering is the DeepView System, which integrates multispectral imaging optics and sensors with proprietary algorithms to evaluate wound healing potential. The platform delivers immediate, binary assessments that differentiate between non-healing and healing tissue, particularly for burn indications. Its operational framework incorporates two commercial models: a software licensing structure featuring maintenance, data hosting, and algorithmic updates, alongside a proprietary imaging hardware component. These clinical tools are designed to assist healthcare professionals in making timely treatment and triage decisions across emergency rooms, trauma centers, and burn units.

Company profile, executives and history

Spectral AI stock: common questions

What is Spectral AI's stock price?

MDAIW closed at $0.45 on Oct 30, 2026, down 8.55% on the day. Over the past 52 weeks it traded between $1.18 and $2.97.

What is Spectral AI's market cap?

Spectral AI was worth $49.24M at the close on Oct 30, 2026: the share price times the diluted shares outstanding.

What is MDAIW's P/E ratio?

Spectral AI lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.34), so it has no meaningful P/E ratio.

How much revenue does Spectral AI make?

Spectral AI reported revenue of $15.39M for the twelve months to Jun 30, 2026, down 44.1% from a year earlier.

Does Spectral AI pay a dividend?

No. Spectral AI has not paid a cash dividend over the last twelve months.

How has MDAIW stock performed over the past year?

Including dividends, MDAIW returned -38.6% over the past year, against +12.4% for the S&P 500.

Who are Spectral AI's competitors?

Companies most similar to Spectral AI by business, industry and size include HYPR, PROF, BTCY, SRTS, SNOA.